Erratum to: Adv Ther (2017) 34:784–798 DOI 10.1007/s12325-017-0497-8
Author wants to correct the text under the heading of Introduction.
The sentence is written as:
“In the ZENITH study, both treatments had a similar positive effect on regression of cardiac and renal damage, whereas a larger proportion of patients showing carotid plaque regression was observed under zofenopril (31.6% vs. 16.1%; p = 0.047), particularly in the subgroup of patients taking the low dose of zofenopril (30 mg) plus HCTZ 12.5 mg (4.7% vs 10.0% irbesartan 150 mg plus HCTZ 12.5 mg; p = 0.043)”.
The correct sentence should read:
“In the ZENITH study, both treatments had a similar positive effect on regression of cardiac and renal damage, whereas a larger proportion of patients showing carotid plaque regression was observed under zofenopril (31.6% vs. 16.1%; p = 0.047). Interestingly, in the subgroup of patients taking the low dose of zofenopril (30 mg) plus HCTZ 12.5 mg the rate of those exhibiting a carotid plaque at study end was significantly lower than that in the subgroup of patients taking the low dose of irbesartan (150 mg) plus HCTZ 12.5 mg (4.7% vs 10.0%; p = 0.043)”.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Footnotes
The online version of the original article can be found under doi:10.1007/s12325-017-0497-8.